Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Access Campaign 1/8 One of the potential treatment candidates for #COVID19 is #remdesivir, produced by @GileadSciencesGilead has filed for patents on remdesivir in more than 70 countries bit.ly/2QVeK4E 05:11 - 30 Mar 2020